Posts
April 19 2012
Ellenoff Grossman & Schole LLP was the premier sponsor at Deal Flow Media's CrowdFunding Conference, in New York City. Douglas S. Ellenoff, a member of the Firm, opened the conference with his keynote address focusing on the outlook of the CrowdFunding Market. Sarah E. Williams, also a member of the Firm, moderated the panel: Understanding Policy Issues vs. Securities Rules if you're in the CrowdFunding Business.
April 18 2012
Titan Pharmaceuticals,Inc. announced the closing of their Registered Direct offering in the amount of $5,540,000. EG&S acted as counsel to the placement agent.
April 18 2012
ParkerVision announced the closing of their Registered Direct in the amount of $1,963,501. EG&S acted as counsel to the placement agent.
April 11 2012
Dipexium Pharmaceuticals, LLC, a private biotechnology company, closed a venture private placement of Series A membership interests and warrants in an amount of over $500,000. EG&S acted as counsel to Dipexium.
April 11 2012
DARA BioSciences, Inc. announced the closing of their Registered Direct offering in the amount of $10,250,000. EG&S acted as counsel to the placement agent.
April 04 2012
Ellenoff Grossman & Schole LLP was ranked #1 for placement agent representation in PIPE transactions (by number of transactions) for the first quarter of 2012.
April 04 2012
Morria Biopharmaceuticals, PLC announced the closing of their PIPE offering in the amount of $1,100,000. EG&S acted as counsel to the investor.
March 30 2012
Elephant Talk Communications Corp. (Amex: ETAK) issued certain Senior Secured Convertible Notes in the principal amount of $8,800,000 to accredited investors. EG&S acted as issuer's counsel.